USD 14.06
(-0.28%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -12.22 Million USD | 39.39% |
2022 | -20.17 Million USD | -2.67% |
2021 | -19.65 Million USD | -6.22% |
2020 | -18.5 Million USD | -45.52% |
2019 | -12.71 Million USD | -36.47% |
2018 | -9.31 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -2.85 Million USD | 3.75% |
2024 Q2 | -1.55 Million USD | 45.58% |
2023 Q2 | -2.86 Million USD | 34.26% |
2023 Q1 | -4.36 Million USD | -66.9% |
2023 FY | -12.22 Million USD | 39.39% |
2023 Q4 | -2.96 Million USD | -45.15% |
2023 Q3 | -2.04 Million USD | 28.85% |
2022 Q3 | -4.08 Million USD | 39.94% |
2022 Q2 | -6.79 Million USD | -1.72% |
2022 Q1 | -6.68 Million USD | -70.83% |
2022 FY | -20.17 Million USD | -2.67% |
2022 Q4 | -2.61 Million USD | 36.0% |
2021 Q2 | -4.37 Million USD | 15.87% |
2021 Q3 | -6.16 Million USD | -40.91% |
2021 Q4 | -3.91 Million USD | 36.55% |
2021 FY | -19.65 Million USD | -6.22% |
2021 Q1 | -5.2 Million USD | 24.07% |
2020 FY | -18.5 Million USD | -45.52% |
2020 Q1 | -3.09 Million USD | -60.49% |
2020 Q4 | -6.84 Million USD | -45.33% |
2020 Q3 | -4.71 Million USD | -22.61% |
2020 Q2 | -3.84 Million USD | -24.01% |
2019 Q1 | -2.72 Million USD | 0.0% |
2019 Q2 | -2.72 Million USD | 0.0% |
2019 Q3 | -5.33 Million USD | -96.0% |
2019 Q4 | -1.93 Million USD | 63.82% |
2019 FY | -12.71 Million USD | -36.47% |
2018 FY | -9.31 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Acutus Medical, Inc. | -14.36 Million USD | 14.846% |
Cerus Corporation | -30.05 Million USD | 59.309% |
OrthoPediatrics Corp. | -25.76 Million USD | 52.538% |
PetVivo Holdings, Inc. | -10.62 Million USD | -15.136% |
Talis Biomedical Corporation | -66.81 Million USD | 81.697% |
Vivos Therapeutics, Inc. | -17.29 Million USD | 29.296% |
Inogen, Inc. | -109.38 Million USD | 88.82% |
Spectral AI, Inc. | -12.98 Million USD | 5.815% |
Nano-X Imaging Ltd. | -62.58 Million USD | 80.461% |
CVRx, Inc. | -43.1 Million USD | 71.628% |
DIH Holding US, Inc. Warrants | -3.52 Million USD | -246.627% |
Helius Medical Technologies, Inc. | -12.42 Million USD | 1.601% |
Orthofix Medical Inc. | -139.11 Million USD | 91.209% |
Venus Concept Inc. | -28.3 Million USD | 56.802% |
Accelerate Diagnostics, Inc. | -54.02 Million USD | 77.365% |
Bioventus Inc. | -81.72 Million USD | 85.036% |
BrainsWay Ltd. | -4.92 Million USD | -148.204% |
Envoy Medical, Inc. | -18.37 Million USD | 33.433% |
electroCore, Inc. | -18.8 Million USD | 34.969% |
IceCure Medical Ltd | -15.57 Million USD | 21.488% |
Lucid Diagnostics Inc. | -48.48 Million USD | 74.776% |
Monogram Orthopaedics, Inc. | -17.26 Million USD | 29.181% |
MaxCyte, Inc. | -48.29 Million USD | 74.681% |
NeuroOne Medical Technologies Corporation | -11.95 Million USD | -2.29% |
Nexalin Technology, Inc. | -5.69 Million USD | -114.683% |
PAVmed Inc | -68.79 Million USD | 82.224% |
Rapid Micro Biosystems, Inc. | -56.56 Million USD | 78.38% |
RxSight, Inc. | -50.08 Million USD | 75.584% |
Sight Sciences, Inc. | -57.27 Million USD | 78.648% |
SI-BONE, Inc. | -46.93 Million USD | 73.943% |
TELA Bio, Inc. | -44.07 Million USD | 72.254% |
TriSalus Life Sciences, Inc. | -54.15 Million USD | 77.416% |
Treace Medical Concepts, Inc. | -51.42 Million USD | 76.221% |
LivaNova PLC | -68.49 Million USD | 82.147% |
908 Devices Inc. | -42.75 Million USD | 71.4% |
Alphatec Holdings, Inc. | -173.39 Million USD | 92.947% |
Nemaura Medical Inc. | -9.59 Million USD | -27.449% |
NeuroPace, Inc. | -27.17 Million USD | 54.997% |
Apyx Medical Corporation | -17.25 Million USD | 29.144% |
Cutera, Inc. | -156.23 Million USD | 92.172% |
STRATA Skin Sciences, Inc. | -8.6 Million USD | -42.132% |
BioSig Technologies, Inc. | -28.51 Million USD | 57.109% |
Anika Therapeutics, Inc. | -87.63 Million USD | 86.046% |
ClearPoint Neuro, Inc. | -22.44 Million USD | 45.518% |
Integra LifeSciences Holdings Corporation | 111.52 Million USD | 110.965% |
Axonics, Inc. | -26.05 Million USD | 53.068% |
Outset Medical, Inc. | -169.77 Million USD | 92.797% |
IRIDEX Corporation | -10 Million USD | -22.204% |
PROCEPT BioRobotics Corporation | -109.17 Million USD | 88.798% |
IRadimed Corporation | 20.03 Million USD | 161.037% |
Tivic Health Systems, Inc. | -8.24 Million USD | -48.32% |
INVO Bioscience, Inc. | -6.76 Million USD | -80.711% |
Telesis Bio, Inc. | -35.15 Million USD | 65.209% |
Viemed Healthcare, Inc. | 14.33 Million USD | 185.338% |
Varex Imaging Corporation | 32.1 Million USD | 138.097% |
Quipt Home Medical Corp. | 3.91 Million USD | 412.044% |
Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -0.791% |
Pulmonx Corporation | -61.93 Million USD | 80.255% |
Dynatronics Corporation | -2.27 Million USD | -438.0% |
Modular Medical, Inc. | -17.52 Million USD | 30.236% |
ReShape Lifesciences Inc. | -14.63 Million USD | 16.463% |
Semler Scientific, Inc. | 22.25 Million USD | 154.947% |
InMode Ltd. | 195.66 Million USD | 106.25% |
Bruker Corporation | 436.9 Million USD | 102.799% |
Cytosorbents Corporation | -31.2 Million USD | 60.816% |
DexCom, Inc. | 597.7 Million USD | 102.046% |
Align Technology, Inc. | 643.33 Million USD | 101.901% |
Viveve Medical, Inc. | -21.55 Million USD | 43.261% |
ZimVie Inc. | -30.93 Million USD | 60.474% |
Movano Inc. | -29.69 Million USD | 58.811% |
Cytek Biosciences, Inc. | -27.84 Million USD | 56.082% |
Nexalin Technology, Inc. | -5.69 Million USD | -114.683% |
DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -246.627% |
Tandem Diabetes Care, Inc. | -233.23 Million USD | 94.757% |
Profound Medical Corp. | -28.61 Million USD | 57.265% |
Insulet Corporation | 220 Million USD | 105.559% |
enVVeno Medical Corporation | -25.23 Million USD | 51.545% |
Surmodics, Inc. | -5.64 Million USD | -116.634% |
iCAD, Inc. | -7.68 Million USD | -59.045% |
Nuwellis, Inc. | -17.63 Million USD | 30.635% |
Biotricity, Inc. | -8.82 Million USD | -38.521% |
iRhythm Technologies, Inc. | -125.16 Million USD | 90.229% |
Aethlon Medical, Inc. | -12.63 Million USD | 3.225% |
InspireMD, Inc. | -21.14 Million USD | 42.161% |
PAVmed Inc. | -68.79 Million USD | 82.224% |
BIOLASE, Inc. | -17.93 Million USD | 31.822% |
Beyond Air, Inc. | -63 Million USD | 80.591% |
FONAR Corporation | 16.53 Million USD | 173.957% |
AxoGen, Inc. | -21.46 Million USD | 43.02% |
Vivani Medical, Inc. | -26.96 Million USD | 54.649% |
Tactile Systems Technology, Inc. | 18.04 Million USD | 167.784% |
Inari Medical, Inc. | -14.03 Million USD | 12.849% |
UFP Technologies, Inc. | 57.66 Million USD | 121.207% |
QT Imaging Holdings, Inc. | -4.92 Million USD | -148.174% |
Heart Test Laboratories, Inc. | -6.3 Million USD | -93.933% |
Tenon Medical, Inc. | -15.72 Million USD | 22.242% |
Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -63.621% |
Co-Diagnostics, Inc. | -42.7 Million USD | 71.365% |
AdaptHealth Corp. | -598.4 Million USD | 97.956% |
Sintx Technologies, Inc. | -13.35 Million USD | 8.452% |
NanoVibronix, Inc. | -3.43 Million USD | -255.908% |
Quanterix Corporation | -49.7 Million USD | 75.395% |
Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -0.791% |
Sensus Healthcare, Inc. | -382 Thousand USD | -3101.309% |
Pacific Biosciences of California, Inc. | -334.46 Million USD | 96.344% |
TransMedics Group, Inc. | -28.72 Million USD | 57.43% |
ReWalk Robotics Ltd. | -23.61 Million USD | 48.209% |
NeuroMetrix, Inc. | -7.15 Million USD | -70.999% |
Hyperfine, Inc. | -48.11 Million USD | 74.584% |
Establishment Labs Holdings Inc. | -65.02 Million USD | 81.194% |
Biomerica, Inc. | -6.36 Million USD | -92.068% |
Bone Biologics Corporation | -9.42 Million USD | -29.705% |
AVITA Medical, Inc. | -40.4 Million USD | 69.732% |
Bluejay Diagnostics, Inc. | -10.31 Million USD | -18.599% |
Silk Road Medical, Inc | -59.27 Million USD | 79.368% |